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Abstract
Objectives: Volumetry is standard method for evaluating the volumes of the right liver (RL), left liver (LL),
left lateral segments (LLS), total liver (TL) and future liver remnant (FLR). The aim of this study was to
report a simple technique based on measurements of liver angles (angulometry) that can be used to
predict liver ratios.
Methods: Fifty computed tomography (CT) scans obtained in subjects with normal liver were studied.
Four CT scan levels were preselected: level 1 passed by the upper part of the hepatic veins; level 2
passed by the left portal vein branch division; level 3 passed by the right portal vein branch division, and
level 4 passed by the gallbladder bed. Left and right tangent lines passing the liver edges were drawn and
joined to the centre of the vertebra defining the TL angle. Two lines through, respectively, the plane of the
middle hepatic vein and the left portal branches determined the angles of the RL, LL and LLS. Volumetric
and angulometric data obtained on levels 2 and 3 in 50 different subjects were compared.
Results: Level 2 CT scans represented the most accurate way of obtaining angulometric measurements.
The mean standard deviation (SD) angles of the TL and LL were 134 12 ° and 55 12 °, respectively.
The mean  SD percentages of the TL represented by the LL in angulometry and volumetry were
38  7% and 36  6%, respectively (non-significant difference). The mean  SD percentages of the
TL represented by the LLS in angulometry and volumetry were 25  4% and 20  3%, respectively
(P < 0.05). The mean  SD overestimation of the percentage of the TL represented by the LLS in
angulometry was 2.7  7.0%.
Conclusions: Angulometry is a simple and accurate technique that can be used to estimate the ratio of
the FLR to TL volume on one or two CT (or magnetic resonance imaging) slices. It can be helpful for
clinicians, especially before right or extended right hepatectomy and after right portal vein occlusion
techniques.
Received 10 August 2012; accepted 21 January 2013
Correspondence
Reza Kianmanesh, Department of General, Digestive and Endocrine Surgery, Robert Debré University
Hospital, Reims Medical University of Champagne-Ardenne, Avenue du Général Koenig, 51092 Reims
Cedex, France. Tel: + 33 3 26 78 70 95. Fax: + 33 3 26 78 87 39. E-mail: rkianmanesh@chu-reims.fr
Introduction
Modern hepatic surgery, including living donor liver transplanta-
tion, split-liver transplantation and extensive one- or two-step
surgery in conjunction with preoperative portal vein embolization
(PVE) or portal vein ligation (PVL), requires preoperative knowl-
edge of the volume of the future liver remnant (FLR).1,2 Over
the past decade, the standard method of estimating both
FLR and total liver volume (TLV) has been represented by
three-dimensional software-assisted computed tomography (CT)
(SACT) volumetry.2–4 In parallel, multiple formulae accurately
This manuscript was presented at the 10th World IHPBA Congress, Paris,
1–5 July 2012.
DOI:10.1111/hpb.12079 HPB
HPB 2013, 15, 976–984 © 2013 International Hepato-Pancreato-Biliary Association
estimate the ‘standard’ TLV. Both SACT and formulae are useful in
clinical practice. Software-assisted CT is usually performed by
radiologists after i.v. contrast-enhanced CT, whereas formulae
such as those of Tongyoo et al.,2 Yoshizumi et al.,5 Vauthey et al.5
and Hashimoto et al.7 estimate the ‘standard’ TLV based on body
weight (BW) or body surface area (BSA).
The estimation of functional TLV is quite different from that of
volumetric TLV as it may in part relate to the presence of tumour
in the liver. Although these volumes can be manually removed
from TLV using SACT, factors such as age, the presence of liver
steatosis, cholestasis and cirrhotic liver changes may affect the
volume and functionality of the liver. Thus, even if formulae have
the ability to standardize the liver volume calculation, they cannot
always estimate the ratio of FLR to TLV, knowledge of which is
required before extensive liver resection.2,3,6,8
Multimodal treatments such as target therapies (cetuximab,
bevacizumab), in addition to chemotherapies (5-fluorouracil,
oxaliplatin, irinotecan), are becoming increasingly efficient in
reducing the size and number of liver colorectal metastases.9–14
Therefore, surgeons are more often confronted with the need to
define complex multimodal strategies (one- or two-step surgery)
including PVE or PVL with the concomitant use of radiofre-
quency ablation and resection of the primary tumour at the initial
consultation and during multidisciplinary discussions.15–27 This
requires a preoperative appreciation of the volume and quality of
the FLR. In this regard, SACT is mandatory before surgery to
estimate not only the amount of liver to remove, but also, and
principally, to estimate the amount and quality of liver that will
remain. However, in most patients estimations of liver volumes
are not available at the first consultation and may not be at the
time of multidisciplinary discussions. This is also true for patients
with hepatocellular carcinoma (HCC), who may require anatomi-
cal major hepatectomy especially after downsizing by transarterial
chemoembolization (TACE) and/or PVE.28–30 Furthermore, long-
term chemotherapies and multiple sequences of TACE or intra-
arterial chemotherapy may affect the nature of the non-tumorous
liver parenchyma.30–38
The aim of this study was to report an easy and reproducible
technique designated ‘liver angulometry’, which is based on the
calculation of liver angles in two liver CT [or magnetic resonance
imaging (MRI)] slices and can be used to assess the volumes of the
total liver (TL), right liver (RL) and left liver (LL).
Materials and methods
Study design
The study was designed in three parts. The first part was intended
to define which of four CT liver levels provided the most accurate
estimate of the ratios between the RL, LL and TL in 50 consecutive
subjects. In the second part, angulometric data were compared
with volumetric data obtained by SACT in another 50 subjects
using the most accurate CT scan level(s) identified in the first part
of the study. The last part of the study was intended to report an
example of angulometry estimating the FLR hypertrophy ratio
after PVE or PVL.
Subjects
Intravenous contrast-enhanced CT scans obtained in 100 adults
(> 15 years of age) without liver tumours (primary, secondary
including liver cysts or other benign liver disease), steatosis,
cholestasis, biliary or vascular disease were analysed in two French
university hospitals (Louis Mourier University Hospital, Paris,
and Reims University Hospital, Reims). Patients with previous
hepatectomy, PVE or PVL were excluded from the two first parts
of the study. Patients with previous uncomplicated cholecystecto-
mies were included in this study.
Methods
The first 50 CT scans of the liver were classified according to four
levels (Fig. 1). Level 1 corresponded to the upper part of the LL
along the plane of Couinaud’s segment VIII (sVIII), segment IV
(sIV) and segment II (sII) so that the three hepatic veins were
visible inside the liver parenchyma. Level 2 corresponded to the
plane of the left portal vein and branches. Level 3 corresponded to
the plane of the right portal vein and branches. Level 4 corre-
sponded to the lowest liver level at the plane of the gallbladder or
gallbladder bed in cholecystectomized patients.
After preliminary adjustments, the centre of the vertebral body
was considered as the ‘C’ point. From this point, the TL angles
were calculated according to two exterior lines passing tangen-
tially by the edges of the left lateral segments (LLS) and RL
(Fig. 1). Then, a middle ‘M’ line in the plane of the middle hepatic
vein determined the limits between the RL and LL. This provided
four levels of liver (L1 to L4) in which TL, RL and LL angles and
the ratios between them could be calculated.
In the second part of the study, the two liver levels that provided
the best estimates of RL and LL ratios were selected. Software-
assisted CT volumetric data obtained using the OsiriX application
(Version 3.9.4, 32 bits; Pixmeo SARL, Geneva, Switzerland)39,40 in
50 different subjects were compared with angulometric data
obtained on levels 2 and 3, and reviewed by an independent radi-
ologist who validated volumetric and angulometric data for final
analyses.
The last part of the study reports an example of an angulom-
etric estimation of the FLR : TLV ratio before and after portal vein
occlusion. Indeed, in most patients, the FLR corresponds to the LL
or LLS (segments II and III). To calculate the LLS angle corre-
sponding to the FLR, a line passing the central part of the left
portal branches (close to the sIII and sIV portal branches on level
2 and passing through the round ligament on level 3) was defined
(Fig. 2). To estimate the TLV, a simple formula close to the for-
mulae reported previously was used on the basis that liver weight
corresponds to 2.0–2.2% in Theoritical TLV (in litres) = 2% of
BW (kg). Therefore, LLS volume (in litres) = (LLS: TLV angle
ratio) ¥ TLV (in litres).
HPB 977
HPB 2013, 15, 976–984 © 2013 International Hepato-Pancreato-Biliary Association
Figure 1 Four levels of angulometry. Level 1 corresponds to the upper part of the liver on the plane of Couinard segments II, IV and VIII, where
the three hepatic veins are visible inside the liver parenchyma. Level 2 corresponds to the plane of the left branch of the portal vein. Level
3 corresponds to the plane of the right portal vein and sectorial branches. Level 4 corresponds to the lower level of the plane of the
gallbladder. C, central point on the vertebral body; M, middle line
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Statistical analyses
Descriptive data were expressed as the median and range, or as the
mean  standard deviation (SD). Quantitative data were com-
pared using non-parametric tests. Qualitative data were compared
using the chi-squared test. 95% confidence intervals (CIs) were
calculated. A P-value of < 0.05 was considered to indicate statis-
tical significance. Regression lines between angulometric and
volumetric values were generated and a two-tailed paired t-test
was used to compare values.
Results
The characteristics of subjects used in the first part of the study (n
= 50) are presented in Table 1. Angulometric data for the LL, RL
and TL, obtained on four different liver levels, are represented in
Table 2. Levels 2 and 3 were the most accurate levels at which to
determine TL, RL and LL angles and ratios. Mean SD angles on
level 2 were 134  12 ° for the TL and 55  12 ° for the LL. The
mean LL : TL ratio on level 2 was 0.38 (range: 0.18–0.54). The
comparison between ratios showed that the LL : TL ratio was
overestimated at level 1, whereas the posterior part of the RL was
overestimated at level 4. Morphometric data showed that 35% of
patients in this series had an ‘L < R volume predominant liver’
meaning that the LL had a > 40 ° development to the LL edge on
level 1, whereas 29% of patients had a ‘deep liver’, in which an RL
angle of > 10 ° developed posteriorly from a horizontal line
passing by the ‘C’ point on level 4 (Fig. 3).
The comparisons between volumetric data obtained by SACT
and angulometric data (observed on levels 2 and 3) in the remain-
ing 50 patients showed no statistical difference between ratios of
RL : TL and LL : TL. Level 2 was the most accurate level for esti-
mating LL ratios. On this level, mean  SD angulometric versus
Figure 2 The angle of the left lateral segment (LLS) corresponds to the angle delimited by a line passing by the central part of the left portal
branches close to Couinard segments II, III and IV on level 2 (L2) and by the round ligament on level 3 (L3)
Table 1 Characteristics of subjects assessed in the first part of the
study (n = 50)
Sex, male/female 17/33
Age, years, mean  SD 45.5  15.0
Body weight, kg, mean  SD 67  11
Height, cm, mean  SD 167  7
BMI, kg/m2, mean  SD 23.9  3.0
Patients with previous cholecystectomy, n 9
SD, standard deviation; BMI, body mass index.
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volumetric LL : TL ratios were 38 7% (95% CI 18–54) versus 36
 6% (95% CI 15–52), respectively (non-significant). Contrary to
the LL : TL ratio, the mean LLS : TL ratio differed significantly
according to whether data were obtained by angulometry or vol-
umetry at 25  4% (95% CI 20–31) versus 20  3% (95% CI
13–25), respectively (P < 0.05) (Fig. 4). However, the mean  SD
percentage of this overestimation of the LLS : TL ratio in angu-
lometry versus volumetry was 2.7  7%.
Formulae might lead to a standard definition of TLV based
on BW or BSA. Angulometric data might estimate LL : TL or
LLS : TL ratios that correspond to the FLR in most patients who
require right or extended right hepatectomy. Consequently, as a
first-line tool one or two CT (or MRI) slices can be used to
determine easily whether there is a need to perform PVE or PVL
before right or extended right hepatectomies. In addition, prelimi-
nary results showed that the comparison between the LL and LLS
angles before and after right PVE (or PVL) may by itself suggest
whether there is (or not) a significant degree of LL hypertrophy
(Fig. 5).
Discussion
The results of this study showed that angulometry is a simple
technique that can help clinicians to accurately calculate the
LL : TL and LLS : TL ratios based on one or two CT (or MRI)
slices obtained on the plane of the left or right portal veins
(levels 2 and 3). The technique can be used to easily predict
the FLR : TLV ratio and provide orientation for strategies
Table 2 Left liver and right liver angulometric data obtained on four levels of computed tomography liver scans in 50 subjects
Left liver angles, ° Right liver angles, °
Median (range) Mean  SD Median (range) Mean  SD
Level 1 58 (41–101) 63  13 75 (15–107) 72  15
Level 2 56 (30–82) 55  12 79 (58–132) 78  12
Level 3 56 (23–95) 55  13 77 (50–104) 77  9
Level 4 51 (23–87) 51  14 73 (56–87) 70  7
SD, standard deviation.
Figure 3 Morphometric data showed that 35% of patients had ‘L> R
predominant liver’ meaning that the left liver had a > 40 ° develop-
ment to the left liver edge on level 1 (L1), and 29% of patients had a
‘deep liver’, with a right liver angle of > 10 ° developed posteriorly
from a horizontal line passing point C on level 4 (L4)








Figure 4 On level 2, mean  standard deviation (SD) left liver : total
liver ratios obtained in angulometry and volumetry, respectively,
were 38  7% (range: 18–54%) and 36  6% (range: 15–52%),
respectively (P = not significant). Mean  SD left lateral segment-
s : total liver (LLS : TL) ratios obtained in angulometry and volumetry
differed significantly at 25  4% (range: 20–31%) and 20  3%
(range: 13–25%), respectively (P < 0.05). The mean SD percentage
of angulometric overestimation of the LLS : TL ratio was 2.7  7.0%
980 HPB
HPB 2013, 15, 976–984 © 2013 International Hepato-Pancreato-Biliary Association
including right PVE or two-step surgery with right PVL, especially
in patients who have undergone a long period of systemic
chemotherapy and who may present with an injured liver
parenchyma.21–23,25,32,41 The technique can also be applied retro-
spectively with ease, if necessary.
Many formulae based exclusively on BSA (or BW) are available
and can accurately estimate TLV without taking into account
volumes that may relate to liver tumours or vascular elements.2
However, although these formulae give an accurate estimation of
standard liver volume (weight), they cannot estimate the volume
of the RL or LL, nor that of the FLR, and should therefore be
combined with SACT volumetry in clinical practice. Indeed, to
avoid postoperative liver failure caused by a remaining liver
volume that is small for size, the FLR is required to amount to at
least 25–30% of the TLV in patients with strictly normal liver
parenchyma or in liver transplantation, and 40% in patients with
an injured liver parenchyma.3 Injured liver parenchyma includes
fibrotic and cirrhotic liver, and organs with chronic liver disease.
More and more patients with colorectal liver metastases receive
prolonged chemotherapy (or targeted therapies) that may affect
the nature of the liver parenchyma.32,33,42–45 Thus, knowledge of the
lower limit of the FLR : TLV ratio is crucial if postoperative liver
failure and infection are to be avoided. Schindl et al.46 studied 104
patients subjected to liver resection and reported a statistical cor-
relation between the percentage of a smaller FLR and postopera-
tive liver failure and postoperative infectious complications. In
this series, an FLR of < 26.6% of TLV was identified as critically
related to the occurrence of severe hepatic dysfunction (P <
0.0001) in patients subjected to liver resection for colorectal
metastases. Consequently, lower limits for the FLR equivalent to
30% of TLV in patients with normal liver and > 40% in patients
with underlying injured liver parenchyma are recommended.3,6
Even if SACT remains the reference standard technique for the
evaluation of liver volumes and ratios, several minor critical
points should be reconsidered. Firstly, it is vital to ensure correct
liver edging and thickness slicing, especially at the juncture
46 °/ 122 °
LLS : TL = 0.38
43 °/ 126 °








68 °/ 148 °
LLS : TL = 0.46
68 °/ 152 °
LLS : TL = 0.45
Figure 5 This patient initially presented with multiple bilobar colorectal liver metastases (type III) that became resectable after 12 cycles of
chemotherapy (5-fluorouracil, oxaliplatin and irinotecan). The hypertrophy progression rates after the laparoscopic first step, including
radiofrequency ablation (RFA) of the left lateral segment (LLS) nodules, plus right portal vein ligation (PVL) showed significant changes in
LLS : total liver (LLS : TL) ratios measured on levels 2 and 3 (L2 and L3). After right PVL, LLS angles progressed from 46° to 68° on L2 and
from 43° to 68° on L3. The progression LLS: TL angulometric ratios were from 38% to 46% and from 34% to 45% on L2 and L3 respectively
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between the RL and LL, and before and after PVE, particularly on
the plane of the middle hepatic vein. Secondly, it should be noted
that some circumstances may cause some variation in liver
volumes such as those related to tumour volume. These circum-
stances may refer to the administration of systemic or intra-
arterial treatments for liver metastases, as well as for liver
primaries, such as HCC. Thirdly, the inclusion (or exclusion) of
the volume of major vessels, including the porta hepatis, inferior
vena cava, origin of the hepatic veins and round ligament, in the
TLV should be considered. Finally, liver volume may vary accord-
ing to the nature of the underlying disease or chemo-induced liver
diseases, including hepatosteatosis, steatohepatitis, sinusoidal
obstructive syndrome (SOS), nodular hyperplastic lesions (regen-
erative nodular hyperplasia), cholestasis, fibrosis and liver cirrho-
sis. These issues may in part explain the variations observed
between volumetric data and those published after partial graft
weighting in living donor transplantation.47 In addition, when
SACT is not available, the present authors believe that a simple
first-line tool such as angulometry could present a valid alterna-
tive method for estimating the FLR : TLV ratio. Indeed, the
importance of estimating the volume of the FLR has been shown
in the past. Ribero et al.3 reported that estimation of the FLR : TLV
ratio could help to anticipate indications for right PVE or PVL
and increase the safety of RL resections. Abdalla et al.48 measured
liver volumes in 102 Western patients without underlying liver
disease. They found that, on average, the LL represented around
33% of the TLV. The LLS represented approximately half of the
volume of the LL or 15–16% of TLV. However, a large degree of
inter-patient variability in liver volume was observed, with the
contributions of the RL and LL to the TLV ranging from 49% to
82%, and 17% to 49%, respectively. Notably, the LLS accounted
for 5–27% of TLV, representing 20% of the TLV in more than 75%
of patients.48 Angulometric findings in the present series concord
with previously reported volumetric data. However, it is impor-
tant to note that levels 1 and 4 do not provide accurate estimations
of RL : TL or LL : TL ratios. Moreover, levels 2 and 3 were found to
be the most appropriate for estimating liver volumes and ratios
between volumes. However, in the present study, a tendency to
overestimate LL : TL and LLS : TL ratios was observed on both
levels 2 and 3. Thus, the mean percentage of this overestimation
between angulometry and volumetry data was 2–5%. This over-
estimation is probably related to the presence of variations in the
left lobe in the thickness of the anterosuperior part of the LLS and
to the edging technique, which requires that a line be drawn
tangentially from the edge of the LLS to the ‘C’ point.
Clinicians, and especially liver surgeons working in the setting
of tertiary cancers, are confronted with the need to give opinions
to patients who present with multiple liver metastases and/or
complex liver tumours. Not all patients routinely undergo SACT.
Therefore, the angulometric estimation of the LLS : TL ratio using
level 2 CT represents an interesting tool with which to predict the
necessity of complex strategies. In this setting, the role of liver
angulometry is not to replace SACT, but to serve as a first-line tool
that will assist in making decisions on whether or not to perform
PVE or PVL, especially in patients who require a right or extended
right hepatectomy.
In addition, when angulometric LL : TL and LLS : TL ratios are
measured, the FLR can be calculated according to the BW of the
patient. For example, an adult with a BW of 100 kg will have an
estimated standard TLV of 2000 ml. This patient may need an
extended right hepatectomy or right hepatectomy with radiofre-
quency ablation on the LL for chemosensitive colorectal liver
metastases. If, in this patient, the ratios of LLS : TL (FLR) obtained
on levels 2 and 3 are 20% and 22%, respectively, his FLR volume
might be estimated as 400–440 ml (20–22% of 2000 ml). It
appears that this patient should benefit from techniques such as
PVE or two-step surgery with PVL in order to increase the safety
and tolerance of the extended right hepatectomy, especially if he
received more than five cycles of chemotherapy.32,41 Furthermore,
if at 3–5 weeks after right PVE, the same patient does not have any
hypertrophy in the LLS : TL ratio on angulometry, or even if
exclusively LLS angle measurements (FLR) remain unchanged,
PVE can be considered to have failed and the indications for
extended right hepatectomy should be reconsidered as this strat-
egy now appears to be highly risky.46,49 It is the present authors’
opinion that this issue is particularly interesting in patients who
require right or extended right hepatectomy and who present with
liver parenchyma injured by either fibrosis or longterm chemo-
therapy. For example, patients with RL large HCC on cirrhotic
liver might benefit from TACE and PVE before right hepatectomy.
If the FLR angles do not increase after 4 weeks, indications for
right hepatectomy should be reconsidered. In addition, in cir-
rhotic patients with enlarged or shrunken livers, volumetric TLV
assessment may be inaccurate if it is measured according to func-
tional tests, such as indocyanine green retention at 15 min. In
these instances, the only way to judge the capacity of the FLR to
regenerate is to measure, by either standard volumetry or angu-
lometry, the degree of hypertrophy of the LL following PVE
and/or TACE.50,51
In conclusion, angulometry is not intended to replace SACT,
which remains the reference standard method for estimating FLR
and TL volumes, but should be regarded as an easy-to-use and
cost-effective way of estimating liver volumes and ratios. It can be
useful in patients with multiple liver metastases and in those with
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